文献速递白血病造血干细胞移植与细胞治疗

杀伤细胞免疫球蛋白样受体与人类白细胞抗原基因型对急性髓系白血病免疫治疗疗效的影响

Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia.
PubMed 文献 · Leukemia · 2017-05-22

该研究在81例接受组胺二盐酸盐联合低剂量IL-2免疫治疗以预防复发的急性髓系白血病患者中检测NK细胞表型及KIR/HLA基因型,发现存在未受训NK细胞与临床结局改善相关,且高NKp46表达带来的临床获益仅限于缺失配体基因型和/或KIR B/x基因型患者。

要点

  • 在81例接受组胺二盐酸盐联合低剂量IL-2免疫治疗的急性髓系白血病患者中,未受训NK细胞的存在与临床结局改善相关。
  • 高表达自然细胞毒性受体NKp46的功能性NK细胞与临床获益相关,但该获益仅限于缺失配体基因型和/或KIR B/x基因型患者。
  • KIR/HLA基因型 favoring NK细胞自反应性的患者中,功能性NK细胞可能是重要的抗白血病效应细胞。

核心结论

  • 功能性NK细胞在KIR/HLA基因型利于NK细胞自反应性的患者中是重要的抗白血病效应细胞。

研究设计与样本

  • 研究纳入81例接受组胺二盐酸盐联合低剂量IL-2免疫治疗以预防复发的急性髓系白血病患者(NCT01347996),检测NK细胞表型及KIR/HLA基因型。

主要发现

  • 未受训NK细胞的存在与临床结局改善相关,尤其在高表达NKp46的功能性NK细胞患者中。
  • 基因型分析提示高NKp46表达的临床获益仅限于缺失配体基因型和/或KIR B/x基因型患者。

关键数值与推荐

  • KIR B/x和缺失配体基因型可能导致潜在自反应性、未受训的NK细胞。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Interactions between killer-immunoglobulin-like receptors (KIRs) and their HLA class I ligands are instrumental in natural killer (NK) cell regulation and protect normal tissue from NK cell attack. Human KIR haplotypes comprise genes encoding mainly inhibitory receptors (KIR A) or activating and inhibitory receptors (KIR B). A substantial fraction of humans lack ligands for inhibitory KIRs (iKIRs), that is, a 'missing ligand' genotype. KIR B/x and missing ligand genotypes may thus give rise to potentially autoreactive, unlicensed NK cells. Little is known regarding the impact of such genotypes in untransplanted acute myeloid leukemia (AML). For this study, NK cell phenotypes and KIR/HLA genotypes were determined in 81 AML patients who received immunotherapy with histamine dihydrochloride and low-dose IL-2 for relapse prevention (NCT01347996). We observed that presence of unlicensed NK cells impacted favorably on clinical outcome, in particular among patients harboring functional NK cells reflected by high expression of the natural cytotoxicity receptor (NCR) NKp46. Genotype analyses suggested that the clinical benefit of high NCR expression was restricted to patients with a missing ligand genotype and/or a KIR B/x genotype. These data imply that functional NK cells are significant anti-leukemic effector cells in patients with KIR/HLA genotypes that favor NK cell autoreactivity.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Bernson E, Hallner A, Sander FE, et al. Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia. Leukemia. 2017. PMID: 28529313. doi:10.1038/leu.2017.151

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。